Viral or non viral gene therapy, in brain

Click For Summary
SUMMARY

This discussion focuses on the implications of viral versus non-viral gene therapy in the human brain, specifically regarding the addition of extra gene copies. Key concerns include potential negative health effects from viral gene therapy, such as the need for stereotaxic neurosurgery and the generation of antibodies against viral capsid proteins. It is established that while initial administration of viral vectors may be safe, long-term expression is crucial to mitigate the need for subsequent treatments. Non-viral gene therapy, particularly using plasmid DNA, is deemed less effective in this context.

PREREQUISITES
  • Understanding of viral gene therapy techniques, specifically AAV (Adeno-Associated Virus).
  • Knowledge of stereotaxic neurosurgery procedures.
  • Familiarity with immune responses to viral vectors, including antibody generation.
  • Basic concepts of non-viral gene therapy methods, particularly plasmid DNA.
NEXT STEPS
  • Research the safety profiles of various viral vectors used in gene therapy.
  • Explore advancements in stereotaxic neurosurgery techniques for gene delivery.
  • Investigate the mechanisms of immune response to viral capsid proteins in gene therapy.
  • Examine the efficacy of non-viral gene therapy methods compared to viral approaches.
USEFUL FOR

Researchers in gene therapy, neuroscientists, and medical professionals involved in developing and administering gene therapies for neurological conditions.

bioquest
Messages
319
Reaction score
0
Im not sure if anybody here can answer this, but, this is my question

What negative health effects etc can occur from viral gene therapy being used on a human brain (to add one or more extra copies of a gene)

what are the odds of those negative effects occurring in the person from viral gene therapy being used on a human brain? (To add one or more extra copies of a gene)

Would non viral gene therapy in a human brain be effective enough to add one or more extra copies of a gene?

These questions are in regards to each type etc of virus though, not just AAV.

thanks..not sure if this is the area of expertise of anyone here but anyways
 
Biology news on Phys.org
one negative effect is delivery of virus to the brain that would most likely involved stereotaxic neurosurgery. another negative effect is antibodies being generated to the viral capsid proteins but i think you will probably be OK with the first administration, so as long as you have long-term expression from your viral vector you will not have to worry about a second administration. viral gene therapy to the brain is a promising platform.

non-viral gene therapy sucks (i assume you are talking about plasmid DNA).
 

Similar threads

Replies
1
Views
2K
  • · Replies 2 ·
Replies
2
Views
2K
  • · Replies 4 ·
Replies
4
Views
3K
Replies
20
Views
5K
Replies
4
Views
4K
  • · Replies 1 ·
Replies
1
Views
3K
  • · Replies 4 ·
Replies
4
Views
4K
  • · Replies 12 ·
Replies
12
Views
3K
  • · Replies 1 ·
Replies
1
Views
3K
  • · Replies 9 ·
Replies
9
Views
7K